MEI gains on preliminary AML data for pracinostat

MEI Pharma Inc. (NASDAQ:MEIP) gained $0.89 (15%) to $7.03 on Tuesday after reporting that oral pracinostat (formerly SB939) met the pre-specified criteria to advance to the second stage of an open-lab...